Esubmissions Requirements New Applications 1
Esubmissions Requirements New Applications 1
Website addresses to each National Competent Authority can be found at the Heads of Medicines Agencies website (www.hma.eu) and in Notice to Application volume 2A chapter 7.
Relevant e-mail addresses for electronic response documents in MRP and DCP can also be found at the Heads of Medicines Agencies website (www.hma.eu – CMD(h) – Contact points).
For all electronic submissions, the eCTD format is highly recommended. However, in general, the Non-eCTD electronic submission format (NeeS) is also accepted.
Please, refer to the Notice to Application volume 2B for the eCTD specifications and otherwise to the document “Guidance for Industry on Providing Regulatory Information in Electronic Format: Non-eCTD electronic
Submissions (NeeS)” – to be endorsed and published by the EU Telematic Implementation Group for electronic submissions (TIGes) at the EMEA website (http://www.emea.europa.eu/).
Please, also seek advice at different NCA’s websites if specific format requirements are stated by footnotes in the table below.
The electronic submission should be provided on CD (or preferably on DVD if not fitted into one CD) unless otherwise stated by the use of footnotes in the table below.
The application form and cover letter should always be submitted in signed paper original, unless otherwise stated by the use of footnotes in the table below.
The Product Information should always be in QRD/CMD(h) template, (see the CMD(h) Annotated QRD template for MR/DC procedures at the Heads of Medicines Agencies website (http://www.hma.eu/22.html).
Response documents submitted during the MR/DC procedure should comply with the CMD(h) recommendations “Applicant’s response document in MR and DC Procedures Recommended CTD Format” see
http://www.hma.eu/uploads/media/response_ctd.pdf and for eCTDs also with the EU Module 1 Specification V1.2.1 (see http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev2.htm#2b).
Table 1. Electronic submission strongly recommended instead of paper or with only some modules additionally in paper (Number of electronic copies asked for)*
Documentation AT BE BG CY CZ DK DE EE EL ES FI FR HU IE IT LV LT LU MT NL PL PT RO SE SK SI UK IS NO
Module 1-5 electronic only 8 8,9,11
- 1 - - - - - - - - - - - - - - - - - 1 - - - - - - 1 - -
(No additional paper)
Module 1-5 electronic with
- - - - - - - - - - - - - - - - - 1 - - - 410 - - 24,8 14,7 - 1 -
additional paper for Module 1*
Module 1-5 electronic with
1 - - - - - - - 1 - - - 17,8 - - 14,6 16 - 26 - - - 73,6,7 - - - - - 18
additional paper for Module 1-2*
Module 1 -5 electronic with
- - - 1 16,12 - - - - - - - - - - - - - - - - - - - - 1 - - -
additional paper for Module 1-3*
Response Documents electronic
1 1 - - - - - 16 11 - - - 17,8 - - 16 - - 16 11,8 - 410 63 - - - 1 1 -
only (No additional paper)
Table 2. Electronic submission strongly recommended together with the required paper original (Number of electronic copies asked for)*
Documentation AT BE BG CY CZ DK DE EE EL ES FI FR HU IE IT LV LT LU MT NL PL PT RO SE SK SI UK IS NO
Electronic copy of Module 1-5* - - 1 - 15 3 2 1 - - 2 5 - 1 18 15 15 - 25 - 43 - 13,5,7 1 - - - - -
Electronic copy of Product
- - - - 1 1 12,8 1 1 - 1 5 - 1 - - - - 1 - 13 - 15 1 - - - 1 -
Information in word format
Electronic copy of Module 2 in
- - - - - - - - 1 - - 26/45 - - - - - - - - - - - 1 - - - - -
word format
Electronic copy of Response
- - 1 1 - 11 22 15 - - 11 22 - - - 15 - - 15 - 43 - 15 1 - - - 1 -
Documents
*For numbers of paper copies requested, please refer to Notice to Application volume 2A chapter 7, section 3.1. Please note that some NCAs may require a reduced number of paper copies if electronic copies are provided.